Barbados research company announces new cancer drug

The original article can be found on: Caribbean News Now

By Caribbean News Now contributor

WORTHING, Barbados — Goff Hill Ltd, a pharmaceutical research development company in Barbados, has announced a new cancer drug that it claims causes cancer tumour cells to completely disintegrate with one five-day treatment.

Goff Hill’s cancer agent reportedly eliminates the control molecule for all cancer cell development, with the resulting disintegration of the cancer cell. There is no scar tissue remaining. Claimed to be clinically proven, it is said to be a cure for primary brain, breast, lung, and colon cancer tumours. The drug is directed only at the cancer cells and has no side effect on normal cells.

There is no toxicity. There were no seizures in the treated patients for brain cancer. There is no residual scar evidence after the disintegrated tumor cells are cleaned up by the janitor cells (megakarocytes), the company said in a press release.

“This is new medical science. Our drug controls the trigger to cancer cell development. The Goff Hill Limited cancer drug, in a five-day treatment, produces complete disintegration of the tumour. Our cancer drug is a cure for primary brain tumours, breast, colon, and lung tumours,” the release stated.

Leave a Comment

Security Question * Time limit is exhausted. Please reload CAPTCHA.

Powered by WordPress